149 related articles for article (PubMed ID: 11872369)
41. Autoantibody against, malondialdehyde-modified low density lipoprotein in patients with non-diabetic unstable angina: a potential role in immunologic reaction of plaque instability.
Kwon KH; Kwon HM; Hong BK; Kim DS; Lee JY; Ryu SK; Park BE; Park HY; Kim JH; Yoon YW; Cho SY; Kim HS
Yonsei Med J; 2002 Apr; 43(2):203-10. PubMed ID: 11971214
[TBL] [Abstract][Full Text] [Related]
42. The Correlation of Serum Myeloid-Related Protein-8/14 and Eosinophil Cationic Protein in Patients with Coronary Artery Disease.
Xia GL; Wang YK; Huang ZQ
Biomed Res Int; 2016; 2016():4980251. PubMed ID: 27022611
[TBL] [Abstract][Full Text] [Related]
43. Thioredoxin in coronary culprit lesions: possible relationship to oxidative stress and intraplaque hemorrhage.
Nishihira K; Yamashita A; Imamura T; Hatakeyama K; Sato Y; Nakamura H; Yodoi J; Ogawa H; Kitamura K; Asada Y
Atherosclerosis; 2008 Dec; 201(2):360-7. PubMed ID: 18420212
[TBL] [Abstract][Full Text] [Related]
44. Spotty calcification typifies the culprit plaque in patients with acute myocardial infarction: an intravascular ultrasound study.
Ehara S; Kobayashi Y; Yoshiyama M; Shimada K; Shimada Y; Fukuda D; Nakamura Y; Yamashita H; Yamagishi H; Takeuchi K; Naruko T; Haze K; Becker AE; Yoshikawa J; Ueda M
Circulation; 2004 Nov; 110(22):3424-9. PubMed ID: 15557374
[TBL] [Abstract][Full Text] [Related]
45. Significance of small dense low-density lipoproteins and other risk factors in patients with various types of coronary heart disease.
Koba S; Hirano T; Kondo T; Shibata M; Suzuki H; Murakami M; Geshi E; Katagiri T
Am Heart J; 2002 Dec; 144(6):1026-35. PubMed ID: 12486427
[TBL] [Abstract][Full Text] [Related]
46. Impact of coronary artery remodeling on clinical presentation of coronary artery disease: an intravascular ultrasound study.
Nakamura M; Nishikawa H; Mukai S; Setsuda M; Nakajima K; Tamada H; Suzuki H; Ohnishi T; Kakuta Y; Nakano T; Yeung AC
J Am Coll Cardiol; 2001 Jan; 37(1):63-9. PubMed ID: 11153774
[TBL] [Abstract][Full Text] [Related]
47. Relation between antibody against oxidized low-density lipoprotein and extent of coronary atherosclerosis.
Tsai WC; Li YH; Chao TH; Chen JH
J Formos Med Assoc; 2002 Oct; 101(10):681-4. PubMed ID: 12517040
[TBL] [Abstract][Full Text] [Related]
48. Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease.
Holvoet P; Vanhaecke J; Janssens S; Van de Werf F; Collen D
Circulation; 1998 Oct; 98(15):1487-94. PubMed ID: 9769301
[TBL] [Abstract][Full Text] [Related]
49. The effects of lipid-lowering therapy on low-density lipoprotein auto-antibodies: relationship with low-density lipoprotein oxidation and plasma total antioxidant status.
Orem C; Orem A; Uydu HA; Celik S; Erdöl C; Kural BV
Coron Artery Dis; 2002 Feb; 13(1):65-71. PubMed ID: 11917201
[TBL] [Abstract][Full Text] [Related]
50. Elevation of ceramide and activation of secretory acid sphingomyelinase in patients with acute coronary syndromes.
Pan W; Yu J; Shi R; Yan L; Yang T; Li Y; Zhang Z; Yu G; Bai Y; Schuchman EH; He X; Zhang G
Coron Artery Dis; 2014 May; 25(3):230-5. PubMed ID: 24589572
[TBL] [Abstract][Full Text] [Related]
51. Circulating malondialdehyde-modified low-density lipoprotein levels are associated with the presence of thin-cap fibroatheromas determined by optical coherence tomography in coronary artery disease.
Matsuo Y; Kubo T; Okumoto Y; Ishibashi K; Komukai K; Tanimoto T; Ino Y; Kitabata H; Hirata K; Imanishi T; Akagi H; Akasaka T
Eur Heart J Cardiovasc Imaging; 2013 Jan; 14(1):43-50. PubMed ID: 22573905
[TBL] [Abstract][Full Text] [Related]
52. Quantitative and qualitative derangement of apolipoprotein B-containing lipoproteins as a risk factor for diabetic macroangiopathy in nonobese NIDDM subjects.
Harano Y; Kageyama A; Nakao Y; Hara Y; Suzuki M; Sato A; Ikebuchi M; Shinozaki K; Tsushima M
Diabetes; 1996 Jul; 45 Suppl 3():S31-4. PubMed ID: 8674886
[TBL] [Abstract][Full Text] [Related]
53. Increase in plasma levels of oxidized low-density lipoproteins in patients with coronary spastic angina.
Kugiyama K; Sugiyama S; Soejima H; Kawano H; Sakamoto T; Takazoe K; Ogawa H; Doi H; Yasue H
Atherosclerosis; 2001 Feb; 154(2):463-7. PubMed ID: 11166780
[TBL] [Abstract][Full Text] [Related]
54. Pregnancy-associated plasma protein A as a marker of acute coronary syndromes.
Bayes-Genis A; Conover CA; Overgaard MT; Bailey KR; Christiansen M; Holmes DR; Virmani R; Oxvig C; Schwartz RS
N Engl J Med; 2001 Oct; 345(14):1022-9. PubMed ID: 11586954
[TBL] [Abstract][Full Text] [Related]
55. [Effect of immune response mediated by antigen-specific T cells on plaque stability in coronary heart disease].
Zheng H; Tu Y; Teng ZH
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Jul; 30(7):1610-1, 1614. PubMed ID: 20650780
[TBL] [Abstract][Full Text] [Related]
56. Neutrophil infiltration of culprit lesions in acute coronary syndromes.
Naruko T; Ueda M; Haze K; van der Wal AC; van der Loos CM; Itoh A; Komatsu R; Ikura Y; Ogami M; Shimada Y; Ehara S; Yoshiyama M; Takeuchi K; Yoshikawa J; Becker AE
Circulation; 2002 Dec; 106(23):2894-900. PubMed ID: 12460868
[TBL] [Abstract][Full Text] [Related]
57. Autophagy of monocytes attenuates the vulnerability of coronary atherosclerotic plaques.
Zhao K; Xu XS; Meng X; Li YL; Li JF; Chen WQ
Coron Artery Dis; 2013 Dec; 24(8):651-6. PubMed ID: 24212263
[TBL] [Abstract][Full Text] [Related]
58. Exaggerated myocardial oxLDL amount and LOX-1 receptor over-expression associated with coronary microvessel inflammation in unstable angina.
Neri Serneri GG; Coppo M; Bandinelli M; Paoletti P; Toscano T; Micalizzi E; Chiostri M; Boddi M
Atherosclerosis; 2013 Feb; 226(2):476-82. PubMed ID: 23237633
[TBL] [Abstract][Full Text] [Related]
59. [Effect of xuezhikang on blood lipids, serum oxidized low density lipoprotein, C-reactive protein and fibrinogen in patients with unstable angina pectoris].
Yao QH; Cui CC; Wang JK
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2003 Oct; 23(10):750-2. PubMed ID: 14626188
[TBL] [Abstract][Full Text] [Related]
60. [Comparative study of T cell proliferative response in different types of coronary heart diseases].
Zheng H; Wu SZ; Lai WY
Di Yi Jun Yi Da Xue Xue Bao; 2004 Apr; 24(4):386-8. PubMed ID: 15090304
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
